+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A multi-institution prospective trial of reduced-dose craniospinal irradiation followed by conformal posterior fossa and primary site irradiation and dose-intensive chemotherapy for average-risk medulloblastoma



A multi-institution prospective trial of reduced-dose craniospinal irradiation followed by conformal posterior fossa and primary site irradiation and dose-intensive chemotherapy for average-risk medulloblastoma



International Journal of Radiation Oncology Biology Physics 57(2 Suppl.): S194-S195




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034298509

Download citation: RISBibTeXText


Related references

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. International Journal of Radiation Oncology Biology Physics 70(3): 782-787, 2008

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal (posterior fossa (36 Gy) (for average-risk medulloblastoma. 2008

Concurrent chemotherapy and low-dose craniospinal irradiation followed by conformal posterior fossa tumor bed boost for average risk medulloblastoma Efficacy and patterns of failure. International Journal of Radiation Oncology Biology Physics 54(2 Suppl.): 149, 2002

Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure. International Journal of Radiation Oncology Biology Physics 58(4): 1161-1164, 2004

Concurrent Chemotherapy and Reduced-Dose Cranial Spinal Irradiation followed by Posterior Fossa Tumor Bed Boost for Average-Risk Medulloblastoma: Efficacy and Patterns of Failure. International Journal of Radiation Oncology*biology*physics 78(3): S588-S589, 2010

Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study. Journal of BUON 18(2): 425-429, 2013

Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. Journal of Clinical Oncology 26(7): 1112-1118, 2008

Results of COG ACNS0331: A Phase III Trial of Involved-Field Radiotherapy (IFRT) and Low Dose Craniospinal Irradiation (LD-CSI) with Chemotherapy in Average-Risk Medulloblastoma: A Report from the Children's Oncology Group. International Journal of Radiation Oncology*biology*physics 96(5): 937-938, 2016

Role of amifostine as a cytoprotectant in children ≥ 3 years with average risk (AR) medulloblastoma (MB) treated with craniospinal irradiation (CSI) and 4 courses of cisplatin (CDDP)-based high dose chemotherapy. Journal of Clinical Oncology 24(18_Suppl): 9063-9063, 2016

Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue. Pediatric Blood and Cancer 62(2): 317-321, 2015

Feasibility and outcome of patients with medulloblastoma treated with pre-irradiation chemotherapy and reduced dose craniospinal radiotherapy (csrh) using mycc as a molecular marker for prognosis. Journal of Clinical Oncology 26(15_Suppl): 10040-10040, 2016

SIOP CNS GCT 96 final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for pat. 2013

High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy. Cancer 110(1): 156-163, 2007

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet. Oncology 7(10): 813-820, 2006

SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro-Oncology 15(6): 788-796, 2013